Carcinoembryonic Antigen Market Analysis 2020 | Share Analysis, Market Value, Size Estimation, Future Trends and Global Industry Insights 2025
Global Carcinoembryonic Antigen Market Research Report:
Information by Application (Colorectal Cancer, Pancreatic Cancer, Breast
Cancer, Lung Cancer, and Others), End User (Hospitals and Clinics, Diagnostic
Centers, and Others), and Region (the Americas, Europe, Asia-Pacific, and the
Middle East & Africa)—Forecast till 2025
Market Highlights
Carcinoembryogenic antigen (CEA) is a group of glycoproteins
which are produced during the fetal developmental stages by gastrointestinal
tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA
concentrations. However, smoking and certain medical conditions such as
colorectal cancer, breast cancer etc. can mark the presence of CEA in the body.
Thus, CEA based diagnostic assays are used for the detection of such cancers
and to check the treatment efficiency during the therapeutic period by a
physician.\
Regional Analysis
The Americas account for the largest share in the
carcinoembryogenic antigen market. The Americas mainly include countries like
the U.S. and Canada. Increasing prevalence of cancer and high healthcare
expenditures within the region will boost the market growth over the assessment
period.
Europe is the second highest revenue generating region in
the global carcinoembryogenic
antigen market. Increasing prevalence of cancer, fast adoption of new
technologies and presence of developed countries like Germany and U.K within
the region will boost the market growth during the forecasted period.
On account of the developing medical infrastructure, rising
healthcare expenditure, and increasing government initiatives, Asia Pacific
region is expected to grow the fastest.
The Middle East & Africa is expected to grow slower than
the global average. The Middle Eastern countries, for instance, UAE and Saudi
Arabia dominates the market due to high income and the government support to
improve public health.
Taste the market data and market information presented
through more than 50 market data tables and figures spread over 80 pages of the
project report. Avail the in-depth table of content (TOC) & market synopsis
on “Global Carcinoembryogenic Antigen Market” Research Report – Forecast till
2023.
Market Players
Some of key players profiled in the report are Lee
BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated.,
Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam
plc., Biocare Medical, LLC, and Biocare Medical, LLC.
Segmentation
The global carcinoembryonic antigen market has been
segmented on the basis of application, sampling, and end user.
Based on application, the market has been segmented into
colorectal, pancreatic, breast, lung cancer, and others.
Based on sampling, the market has been segmented into
antecubital, peritoneal, pleural, serebrospinal, and others.
Based on the end users, the market has been segmented into
hospitals, diagnostic centers, research centers, and others.
MRFR team has supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country-level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to
stay updated with the technology and work process of the industry, MRFR often
plans & conducts meet with the industry experts and industrial visits for
its research analyst members.
Contact:
Comments
Post a Comment